This compound is a pharmaceutical intermediate used in the synthesis of edoxaban, an anticoagulant. It features a complex polycyclic structure with multiple amide groups and a chlorine-substituted aromatic ring.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
1-[2-[2-[2-[2-[2-[2-[2-(2-bromoethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]-2-methoxyethane
pharmaceutical intermediate
4-Amino-3,3-difluoro-1-piperidinecarboxylic acid 1,1-dimethylethyl ester
pharmaceutical intermediate
3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxylic acid
pharmaceutical intermediate
(4-Bromo-3-(ethoxymethyl)phenyl)methanol
pharmaceutical intermediate
Edoxaban
pharmaceutical raw material
Edoxaban tosylate
pharmaceutical raw material
N'-(5-chloropyridin-2-yl)-N-[(1S,2R,4S)-4-(dimethylcarbamoyl)-2-{5-methyl-4H,5H,6H,7H-[1,3]thiazolo[5,4-c]pyridine-2-amido}cyclohexyl]ethanediamide
pharmaceutical raw material
Edoxaban tosylate monohydrate
pharmaceutical raw material
N'-(5-chloro-2-pyridinyl)-N-[(1S,2R,4R)-4-(dimethylcarbamoyl)-2-[(5-methyl-6,7-dihydro-4H-[1,3]thiazolo[5,4-c]pyridine-2-carbonyl)amino]cyclohexyl]oxamide
HGVDHZBSSITLCT-UKPHBRMFSA-N
CN1CCC2=C(C1)SC(=N2)C(=O)N[C@@H]3C[C@@H](CC[C@@H]3NC(=O)C(=O)NC4=NC=C(C=C4)Cl)C(=O)N(C)C
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.